Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | RORA | P35398 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | RORB | Q92753 | 1/20 | 0.33 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3437734 | 0.85 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1RORARORCRORB | |
| SCHEMBL23430530 | 0.77 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1RORARORCRORB | |
| SCHEMBL21129236 | 0.77 | GAA (0.37) | ALDH1A1POLBGAANPSR1 | |
| SCHEMBL22426651 | 0.75 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1RORARORCRORB | |
| SCHEMBL12381798 | 0.74 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1RORARORCRORB | |
| SCHEMBL21977159 | 0.73 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1RORARORCRORB | |
| SCHEMBL14447504 | 0.73 | LMNA (0.33) | ALDH1A1MAPTPOLBGAANPSR1 | |
| SCHEMBL24255093 | 0.72 | GAA (0.34) | ALDH1A1POLBGAANPSR1 | |
| SCHEMBL14392306 | 0.72 | ALDH1A1 (0.46) | ALDH1A1POLBGAANPSR1LMNA | |
| SCHEMBL21555337 | 0.71 | ALDH1A1 (0.40) | ALDH1A1KMT2APOLBGAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220145151-A1 | RESIN SHEET | LINTEC CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20200353089-A1 | POLYMERS WITH RIGID SPACING GROUPS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS | Sony Group Corporation (JP) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200353089-A1 | POLYMERS WITH RIGID SPACING GROUPS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS | MRPL21, TLN1, L3MBTL1 | ALDH1A1 2854/4885L3MBTL1 3/4885RORA 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.